| Pharmacy / Pharmacology - Bridging Chemistry and Biology: The Art of Designing Novel Therapeutics |
|
|
|
|
| |
|
| |
The latest pharmacy / pharmacology news from News Medical |
|
|
|
| | |  | | |  In a new study, the scientists show that their synthetic melanin, mimicking the natural melanin in human skin, can be applied topically to injured skin, where it accelerates wound healing. | | | | |  In an exploratory study published in the journal Scientific Reports, researchers from the Netherlands investigated the efficacy of selective serotonin reuptake inhibitors (SSRIs) in the treatment of 95 patients with post-coronavirus disease 2019 (COVID-19) syndrome (PCS). | | | | |  This article will provide insight into the efficacy of anti-anxiety patches as a novel approach to managing anxiety and stress and the potential role they may play in treating anxiety disorders and promoting overall wellbeing. | | | | |  A small clinical trial with a pharmacokinetic sub-study, led by a world-renowned pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury. | | | | |  In a recent article published in the Genes Journal, researchers discussed the significance of pharmacogenomics-based studies in the research for personalized therapeutics for dementia, including drugs targeting both cognitive and non-cognitive symptoms. | | | | |  Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these trends suggest a future in which many more people are at risk of suffering from serious uncorrectable vision loss later in life. | |
|
|
| | | How would you rate today's newsletter?
| |
|
|
|
|
|
|
|
